Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP835816.RAMPgechn_hyW-iTga5wLbbec6AJtQgGAU-lOnVeufFE0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP835816.RAMPgechn_hyW-iTga5wLbbec6AJtQgGAU-lOnVeufFE0130_assertion type Assertion NP835816.RAMPgechn_hyW-iTga5wLbbec6AJtQgGAU-lOnVeufFE0130_head.
- NP835816.RAMPgechn_hyW-iTga5wLbbec6AJtQgGAU-lOnVeufFE0130_assertion description "[Fusion gene products such as PML-RARalpha and BCR-ABL generated by leukemia-specific chromosomal translocations have been identified as target molecules for the treatment of leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP835816.RAMPgechn_hyW-iTga5wLbbec6AJtQgGAU-lOnVeufFE0130_provenance.
- NP835816.RAMPgechn_hyW-iTga5wLbbec6AJtQgGAU-lOnVeufFE0130_assertion evidence source_evidence_literature NP835816.RAMPgechn_hyW-iTga5wLbbec6AJtQgGAU-lOnVeufFE0130_provenance.
- NP835816.RAMPgechn_hyW-iTga5wLbbec6AJtQgGAU-lOnVeufFE0130_assertion SIO_000772 11587362 NP835816.RAMPgechn_hyW-iTga5wLbbec6AJtQgGAU-lOnVeufFE0130_provenance.
- NP835816.RAMPgechn_hyW-iTga5wLbbec6AJtQgGAU-lOnVeufFE0130_assertion wasDerivedFrom befree-20140225 NP835816.RAMPgechn_hyW-iTga5wLbbec6AJtQgGAU-lOnVeufFE0130_provenance.
- NP835816.RAMPgechn_hyW-iTga5wLbbec6AJtQgGAU-lOnVeufFE0130_assertion wasGeneratedBy ECO_0000203 NP835816.RAMPgechn_hyW-iTga5wLbbec6AJtQgGAU-lOnVeufFE0130_provenance.